Stacy Cline Amin spoke to Axios about former Food and Drug Administration chief Robert Califf returning to his role.
Califf will face a Senate Health, Education, Labor, and Pensions Committee hearing on his nomination soon, though Stacy said he’s unlikely to get a floor vote by the end of the year, adding that the committee may not feel as much time pressure because [Woodcock] is “doing a good job and is generally well-liked.”
“This time has been really really hard for the agency,” Stacy said. “The staff is working around the clock. They are exhausted. I think it’s good they chose a nominee who has experience with the agency. It will be a smooth transition, likely. I think that’s important for the workforce there.”